Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.36
Delayed Data
As of 3:59pm ET
 +0.03 / +1.29%
Today’s Change
2.05
Today|||52-Week Range
4.80
+2.61%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.33
Today’s open2.33
Day’s range2.28 - 2.38
Volume54,801
Average volume (3 months)105,434
Market cap$25.5M
Dividend yield--
Data as of 3:59pm ET, 05/25/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-5.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.56

Competitors

 Today’s
change
Today’s
% change
XBIOXenetic Biosciences ...-0.00-0.07%
HTBXHeat Biologics Inc+0.00+0.57%
CLRBCellectar Bioscience...-0.04-2.38%
OGENOragenics Inc+0.01+2.08%
Data as of 3:59pm ET, 05/25/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts